|
Foot Diseases
|
C17.800.321 |
|
|
Australia
|
D001315 |
[The smallest continent and an independent country, comprising six states and two territories. Its capital is Canberra.
] |
|
Facies
|
E01.370.600.230 |
|
|
Ureteral Calculi
|
C12.777.967.374.500 |
|
|
Ureterolithiasis
|
C12.777.967.374 |
|
|
Aurovertins
|
D001313 |
[Very toxic and complex pyrone derivatives from the fungus Calcarisporium arbuscula. They bind to and inhibit mitochondrial ATPase, thereby uncoupling oxidative phosphorylation. They are used as biochemical tools.
] |
|
Auscultation
|
D001314 |
[Act of listening for sounds within the body.
] |
|
Lupus Nephritis
|
C12.777.419.570.363.680 |
|
|
Authorship
|
D001319 |
[The profession of writing. Also the identity of the writer as the creator of a literary production.
] |
|
Austria
|
D001317 |
[A country located in Central Europe, north of Italy and Slovenia. The capital is Vienna.
] |
|
Authoritarianism
|
D001318 |
[The personality pattern or syndrome consisting of behavioral and attitudinal characteristics reflecting a preoccupation with the factors of power and authority in interpersonal relationships.
] |
|
Sodium-Glucose Transporter 2 Inhibitors
|
D27.505.696.422.750 |
|
|
Aurintricarboxylic Acid
|
D001312 |
[A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
] |
|
Leukodystrophy, Globoid Cell
|
C18.452.648.398.641.803.585 |
|
|
Herpes Simplex Virus Vaccines
|
D20.215.894.899.290.400 |
|
|
Auranofin
|
D001310 |
[An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.
] |
|
4-Aminobutyrate Transaminase
|
D08.811.913.477.700.200 |
|
|
Factor XIIa
|
D015956 |
[Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein (with cofactor HIGH MOLECULAR WEIGHT KININOGEN) cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments (Hageman-Factor fragments). These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII.
] |
|
Platelet-Rich Fibrin
|
A15.145.693.600.500 |
|
|
Platelet-Rich Plasma
|
A15.145.693.600 |
|
